• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Regulating Off-Label Promotion - A Critical Test.

作者信息

Robertson Christopher, Kesselheim Aaron S

机构信息

From the Regulatory Science Program and James E. Rogers College of Law, University of Arizona, Tucson (C.R.); New York University School of Law, New York (C.R.); and the Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston (A.S.K.).

出版信息

N Engl J Med. 2016 Dec 15;375(24):2313-2315. doi: 10.1056/NEJMp1611755. Epub 2016 Nov 2.

DOI:10.1056/NEJMp1611755
PMID:27805841
Abstract
摘要

相似文献

1
Regulating Off-Label Promotion - A Critical Test.规范药品未标示用途推广——一项关键考验。
N Engl J Med. 2016 Dec 15;375(24):2313-2315. doi: 10.1056/NEJMp1611755. Epub 2016 Nov 2.
2
Off-label marketing and the First Amendment.药品未按批准适应症用药的营销与第一修正案
N Engl J Med. 2013 Jan 10;368(2):103-5. doi: 10.1056/NEJMp1214926. Epub 2012 Dec 12.
3
Clinical trial transparency--antidote to weaker off-label-promotion rules?临床试验透明度——对抗宽松的未注册推广规则的解药？
N Engl J Med. 2014 Jul 3;371(1):1-3. doi: 10.1056/NEJMp1402969.
4
United States v. Caronia: Off-Label Drug Promotion and First Amendment Balancing.美国诉卡罗尼亚案：药品未标示用途推广与第一修正案平衡
Fordham Law Rev. 2018 Apr;86(5):2595-623.
5
Pros and cons of off-label promotion investigations and prosecutions.药品未按批准说明书用药推广的调查与起诉的利弊
Food Drug Law J. 2006;61(3):577-83.
6
Forbidden and Permitted Statements about Medications--Loosening the Rules.关于药物的禁忌与许可声明——放宽规则
N Engl J Med. 2015 Sep 3;373(10):967-73. doi: 10.1056/NEJMhle1506365.
7
Prospects for Enforcing Prohibitions on Off-Label Drug Promotion after United States v. Caronia: An Analysis of Litigated Cases.美国诉卡罗纳案后禁止药品标签外推广的前景：诉讼案例分析。
J Health Polit Policy Law. 2021 Jun 1;46(3):487-504. doi: 10.1215/03616878-8893571.
8
When true enough is not good enough.当足够真实却还不够好时。
Nat Med. 2013 Jan;19(1):1. doi: 10.1038/nm.3061.
9
Pharmaceuticals and medical devices: FDA oversight. End-of-year issue brief.药品和医疗器械：美国食品药品监督管理局监管。年终问题简报。
Issue Brief Health Policy Track Serv. 2010 Jan 4:1-31.
10
Off-label marketing: free speech or illegal promotion?药品未按批准用途销售：言论自由还是非法促销？
BMJ. 2013 Jan 22;346:f320. doi: 10.1136/bmj.f320.

引用本文的文献

1
Learning from the Opioid Epidemic: Preventing the Next Healthcare Marketing Crisis.从阿片类药物流行中吸取教训：预防下一次医疗保健营销危机。
J Gen Intern Med. 2021 Nov;36(11):3553-3556. doi: 10.1007/s11606-021-06799-1. Epub 2021 Apr 26.
2
Distinguishing moral hazard from access for high-cost healthcare under insurance.区分保险下的高成本医疗保健的道德风险与准入
PLoS One. 2020 Apr 17;15(4):e0231768. doi: 10.1371/journal.pone.0231768. eCollection 2020.
3
Inhaled Pulmonary Vasodilators in Cardiac Surgery Patients: Correct Answer Is "NO".
心脏手术患者吸入性肺血管扩张剂：正确答案是“否”。
Anesth Analg. 2017 Aug;125(2):375-377. doi: 10.1213/ANE.0000000000002239.